<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35103255</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3791</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Cell reports. Medicine</Title><ISOAbbreviation>Cell Rep Med</ISOAbbreviation></Journal><ArticleTitle>Potential role of neurofilament in COVID-19 and preeclampsia.</ArticleTitle><Pagination><StartPage>100490</StartPage><MedlinePgn>100490</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100490</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xcrm.2021.100490</ELocationID><Abstract><AbstractText>Neurofilament light (NFL) is a promising circulating biomarker in preeclampsia and COVID-19, even without evident neurological complications. Several pathways might contribute to the elevated serum NFL levels seen in both pathologies. Future studies will determine whether NFL is a long COVID marker and delineate NFL's role in COVID-19-associated preeclampsia.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samara</LastName><ForeName>Athina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Clinical Paediatrics, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herlenius</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Clinical Paediatrics, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O' Brien</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Royal College of Obstetricians and Gynaecologists, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Asma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fetal Medicine Unit, St George's Hospital, St George's University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fetal Medicine Unit, Liverpool Women's Hospital, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016433">News</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep Med</MedlineTA><NlmUniqueID>101766894</NlmUniqueID><ISSNLinking>2666-3791</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C044882">neurofilament protein L</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="N">Neurofilament Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neurofilament</Keyword><Keyword MajorTopicYN="N">preeclampsia</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">sNFL</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35103255</ArticleId><ArticleId IdType="pmc">PMC8764750</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2021.100490</ArticleId><ArticleId IdType="pii">S2666-3791(21)00367-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Lancet Neurology Long COVID: understanding the neurological effects. Lancet Neurol. 2021;20:247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969137</ArticleId><ArticleId IdType="pubmed">33743226</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Benjamin L.A., Mehta P.R., Brown R.L., Athauda D., Ashton N.J., Leckey C.A., Ziff O.J., Heaney J., Heslegrave A.J., et al. UCLH Queen Square COVID-19 Biomarker Study Group Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Commun. 2021;3:b099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194666</ArticleId><ArticleId IdType="pubmed">34396099</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen K., McKay R.D. Proliferation and differentiation of rat neuroepithelial precursor cells in&#xa0;vivo. J.&#xa0;Neurosci. 1988;8:1144&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6569254</ArticleId><ArticleId IdType="pubmed">3357014</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.A., Barreras P.V., Lewis A., Pinilla G., Sokoll L.J., Kickler T., Mostafa H., Caturegli M., Moghekar A., Fitzgerald K.C., Pardo C.A., Hopkins Neuro-COVID-19 Group Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. J.&#xa0;Neurol. Sci. 2021;427:117517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166041</ArticleId><ArticleId IdType="pubmed">34090021</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Erben Y., Marquez C.P., Jansen-West K.R., Franco-Mesa C., Heckman M.G., White L.J., Dunmore J.A., Cook C.N., Lilley M.T., et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci. Transl. Med. 2021;13:eabi7643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432951</ArticleId><ArticleId IdType="pubmed">34131052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameres M., Brandstetter S., Toncheva A.A., Kabesch M., Leppert D., Kuhle J., Wellmann S. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. J.&#xa0;Neurol. 2020;267:3476&#x2013;3478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7345451</ArticleId><ArticleId IdType="pubmed">32647900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.M., Yilmaz A., Lindh M., Nilsson S., Price R.W., Blennow K., Zetterberg H., Gissl&#xe9;n M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;e1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Lor&#xe9; N.I., Finardi A., Mandelli A., Cirillo D.M., Tresoldi C., Benedetti F., Ciceri F., Rovere-Querini P., Comi G., et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J.&#xa0;Neurol. 2021;268:4436&#x2013;4442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108733</ArticleId><ArticleId IdType="pubmed">33973106</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurol-Urganci I., Jardine J.E., Carroll F., Draycott T., Dunn G., Fremeaux A., Harris T., Hawdon J., Morris E., Muller P., et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am. J. Obstet. Gynecol. 2021;225:522.e1&#x2013;522.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135190</ArticleId><ArticleId IdType="pubmed">34023315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz Melguizo S., de la Cruz Conty M.L., Carmona Pay&#xe1;n P., Abascal-Saiz A., Pintando Recarte P., Gonz&#xe1;lez Rodr&#xed;guez L., Cuenca Mar&#xed;n C., Mart&#xed;nez Varea A., Oreja Cuesta A.B., Rodr&#xed;guez P.P., et al. Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study. Viruses. 2021;13:853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8151603</ArticleId><ArticleId IdType="pubmed">34067086</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J., Ariff S., Gunier R.B., Thiruvengadam R., Rauch S., Kholin A., Roggero P., Prefumo F., do Vale M.S., Cardona-Perez J.A., et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175:817&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063132</ArticleId><ArticleId IdType="pubmed">33885740</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mascio D., Buca D., Berghella V., Khalil A., Rizzo G., Odibo A., Saccone G., Galindo A., Liberati M., D&#x2019;Antonio F. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Ultrasound Obstet. Gynecol. 2021;57:687&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251147</ArticleId><ArticleId IdType="pubmed">33724545</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde-Agudelo A., Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2021;226(1):P68&#x2013;P89. doi: 10.1016/j.ajog.2021.07.009. S0002-9378(21)00795-X. Published online July 21, 2021. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.07.009</ArticleId><ArticleId IdType="pmc">PMC8294655</ArticleId><ArticleId IdType="pubmed">34302772</ArticleId></ArticleIdList></Reference><Reference><Citation>Evers K.S., Atkinson A., Barro C., Fisch U., Pfister M., Huhn E.A., Lapaire O., Kuhle J., Wellmann S. Neurofilament as Neuronal Injury Blood Marker in Preeclampsia. Hypertension. 2018;71:1178&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">29686016</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M., Oras J., Th&#xf6;rn S.E., Karlsson O., K&#xe4;lebo P., Zetterberg H., Blennow K., Bergman L. Signs of neuroaxonal injury in preeclampsia-A case control study. PLoS ONE. 2021;16:e0246786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869986</ArticleId><ArticleId IdType="pubmed">33556141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>